Pfizer said on April 22 that it was voluntarily recalling five batches of its Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine. The drugmaker said it was not aware of any reports of adverse events related to the recalled batches, which were distributed in the United States…
Pfizer Recalls Some Batches of Blood Pressure Drug Over Carcinogen Presence
WHO Backs Pfizer’s Oral COVID-19 Therapy for High-Risk Patients
The World Health Organization (WHO) on April 21 endorsed the use of Pfizer Inc.’s oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by the U.N. agency showed the therapy dramatically cut the risk of hospitalization. Of existing COVID-19 treatments, Pfizer’s Paxlovid is by far the most potent, the WHO said….
Covid ‘Vaccine Fog’ and What to Do About It
April 26, 2022
admin
Ask A Doctorbrain fogbrain healthBrightCOVIDhealthHealth ConditionsInfectious DiseasesNeurological HealthPfizerUncategorizedVaccinevaccine injuriesvaccine injury
0 Comment
People in most countries in the world are already generally vaccinated—by official counts, over 5 billion of the world’s population has received at least one dose of COVID-19 vaccine. But we also know there has been widespread reporting of COVID-19 vaccine injuries, unlike with any other kind of vaccine. We were informed that a 15-year-old…
Severe Infections 5 Times More Likely Among Sinovac Than Pfizer COVID-19 Vaccine Recipients: Study
April 24, 2022
admin
Asia & PacificBrightCCP VirusChinaCovid NewsCOVID-19healthHealth NewsINSIDE CHINAPfizerSingaporeSinovacVaccineVaccines & SafetyWorld
0 Comment
The China-made Sinovac-CoronaVac vaccine is the least effective in preventing infection or severe symptoms among COVID-19 patients compared to the Sinopharm, Moderna, and Pfizer-BioNTech/Comirnaty vaccines, according to a recently published study from Singapore. “We observed a lower relative effectiveness of two inactivated whole virus vaccines (Sinovac-CoronaVac and Sinopharm) against COVID-19 infection compared with two mRNA…
Quebec Judge Favours Mother’s Stance to Have Son Take COVID Shots Without Father’s Consent
A Quebec judge has ruled in favour of a mother who can have her son receive the COVID-19 shots without the father’s consent, and the father is banned from taking the child to participate in COVID-19 protests. In a ruling dated April 12, Superior Court Justice Nathalie Pelletier sided with the 10-year-old’s mother, who said…
Quebec Judge Favours Mother’s Wish to Have Son Vaccinated for COVID Without Father’s Consent
A Quebec judge has ruled in favour of a mother who wants to have her son to receive COVID-19 vaccination without the father’s consent, and has also banned the father from taking the child to participate in COVID-19 protests. In a ruling dated April 12, Superior Court Justice Nathalie Pelletier sided with the 10-year-old’s mother,…
Poland Refuses to Accept and Pay for New COVID-19 Vaccine Deliveries
Poland is refusing to accept or pay for more deliveries of the COVID-19 vaccine under the European Union’s supply contract, amid dwindling demand. The country’s health minister announced the news in remarks on local television on Tuesday. “At the end of last week, we used the force majeure clause and informed both the European Commission…
Facts Matter (April 19): Study Shows Heart Issues in 69% of Children Detected Months After Vaccination
A new study published by researchers at the Seattle Children’s Hospital found that heart abnormalities were detected in some adolescents, months after receiving the COVID-19 vaccine. Specifically, these researchers were reviewing the cases of children who came into their hospital within a week of getting their second dose of the Pfizer vaccine. Stay tuned for…
Pfizer to Ask US Regulators to Authorize COVID Vaccine Booster for 5–11 Age Group
Pfizer and BioNTech plan on asking the U.S. Food and Drug Administration (FDA) to grant emergency use authorization for a booster for their COVID-19 vaccine for children aged 5- to 11-years-old, the companies announced on April 14. The submission will be based on data from a Phase 2/3 clinical trial that showed a boost in…
Pfizer Boosts Respiratory Drug Portfolio With ReViral Purchase
Pfizer Inc. said on Thursday it would buy privately-held ReViral Ltd. in a deal worth as much as $525 million including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus (RSV). The deal marks the U.S. drugmaker’s second acquisition in less than six months to boost its drug portfolio, after a…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`